Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
206 participants
OBSERVATIONAL
2009-06-30
2012-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
INvestigating SIGnificant Health TrendS in the Management of Superficial Vein Thrombosis
NCT02699151
Endovenous Ablation Combined With Fat Grafting for Venous Ulcers
NCT05241704
3-4 Year Outcomes Following Endovenous Steam Ablation for Venous Insufficiency
NCT02944331
Clinical Implications of Genetic Variations of Venous Stasis Ulceration
NCT02034396
Pilot Study to Determine Percent Tissue Perfusion and Cellular Viability Using SPY Imaging
NCT01522495
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No HP802 Treatment
Treatment received in Study 802-247-09-015 was HP802
No HP802 Treatment
No HP802 Vehicle Treatment
Treatment received in Study 802-247-09-015 was HP802 Vehicle
No HP802 Vehicle Treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No HP802 Treatment
No HP802 Vehicle Treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willing to comply with protocol instructions, including allowing all study assessments.
* Subject was randomized in HP 802-247-09-015 and received at least one application of a test article, whether active or placebo.
* Subject has ended their participation in HP 802-247-09-015 by virtue of completing the study, or by dropping out prior to completion.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Healthpoint
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hebert B Slade, MD, FAAAAI
Role: STUDY_DIRECTOR
Healthpoint
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of AZ College of Medicine
Tucson, Arizona, United States
Center for Clinical Research
Castro Valley, California, United States
ILD Consulting, Inc.
Encinitas, California, United States
Vascular Surgery Associates
Los Angeles, California, United States
UCSD Wound Treatment and Research Center
San Diego, California, United States
University of Miami
Miami, Florida, United States
Doctors Research Network
South Miami, Florida, United States
Robert J. Snyder
Tamarac, Florida, United States
Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States
Passavant Area Hospital
Jacksonville, Illinois, United States
Rosalind Franklin University
North Chicago, Illinois, United States
Southern Illinois University
Springfield, Illinois, United States
Johns Hopkins Wound Center
Baltimore, Maryland, United States
Boston Medical Center
Boston, Massachusetts, United States
New England Sinai Hospital
Stoughton, Massachusetts, United States
Advanced Foot and Ankle Center
Las Vegas, Nevada, United States
Vincent Giacalone
Emerson, New Jersey, United States
St. Luke's Roosevelt Hospital Center
New York, New Jersey, United States
Overglook Hospital Wound Healing Program
Summit, New Jersey, United States
University of North Carolina
Chapel Hill, North Carolina, United States
Harrisburg Foot and Ankle Center
Harrisburg, Pennsylvania, United States
Center for Advanced Wound Care
Reading, Pennsylvania, United States
Arlington Research Center
Arlington, Texas, United States
Wound Care Consultants
Dallas, Texas, United States
Southwest Regional Wound Care Center
Lubbock, Texas, United States
Peripheral Vascular Associates
San Antonio, Texas, United States
Dixie Regional Medical Center's Wound Clinic
St. George, Utah, United States
Lake Washington Vascular, PLLC
Bellevue, Washington, United States
Providence Sacred Heart Medical Center Wound Clinic
Spokane, Washington, United States
Aging Rehabilitation & Geriatric Care Research Center
London, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
802-247-09-016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.